Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer.
about
CircRNA: a novel type of biomarker for cancer.PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs.Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.Fluoxetine induces autophagic cell death via eEF2K-AMPK-mTOR-ULK complex axis in triple negative breast cancer.
P2860
Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Crystal structure-based discov ...... triple-negative breast cancer.
@ast
Crystal structure-based discov ...... triple-negative breast cancer.
@en
type
label
Crystal structure-based discov ...... triple-negative breast cancer.
@ast
Crystal structure-based discov ...... triple-negative breast cancer.
@en
prefLabel
Crystal structure-based discov ...... triple-negative breast cancer.
@ast
Crystal structure-based discov ...... triple-negative breast cancer.
@en
P2093
P2860
P1433
P1476
Crystal structure-based discov ...... triple-negative breast cancer.
@en
P2093
Dahong Yao
Liang Ouyang
Mingrui Guo
Peiqi Wang
Shuya Wang
Yaxin Zheng
P2860
P2888
P356
10.1038/S41598-016-0007-2
P407
P577
2016-12-05T00:00:00Z
P6179
1056467548